Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia
Status:
Completed
Trial end date:
2019-05-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether bortezomib in combination with
doxil/lipodox is effective in the treatment of Acute Myeloid Leukemia.